lidocaine hydrochloride injection, solution
general injectables & vaccines, inc - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride anhydrous 20 mg in 1 ml - lidocaine hydrochloride injection administered intravenously or intramuscularly, is specifically indicated in the acute management of ventricular arrhythmias such as those occurring in relation to acute myocardial infarction, or during cardiac manipulation, such as cardiac surgery. lidocaine hydrochloride is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type. lidocaine hydrochloride should not be used in patients with stokes-adams syndrome, wolff-parkinson-white syndrome or with severe degrees of sinoatrial, atrioventricular or intraventricular block in the absence of an artificial pacemaker. although specific studies have not been conducted, lidocaine hcl has been used clinically without evidence of abuse of this drug or of psychological or physical dependence as a result of its use.
glimepiride tablet
rebel distributors corp - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 2 mg - glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (see dosage and administration section ). glimepiride tablets are contraindicated in patients with 1. known hypersensitivity to the drug. 2. diabetic ketoacidosis, with or without coma. this condition should be treated with insulin.
glimepiride tablet
pd-rx pharmaceuticals, inc. - glimepiride (unii: 6ky687524k) (glimepiride - unii:6ky687524k) - glimepiride 2 mg
oxycodone hydrochloride tablet
aurolife pharma, llc - oxycodone hydrochloride (unii: c1enj2te6c) (oxycodone - unii:cd35pmg570) - oxycodone hydrochloride 5 mg - oxycodone hydrochloride tablets is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1)], reserve oxycodone hydrochloride tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or opioid combination products): • have not been tolerated or are not expected to be tolerated, • have not provided adequate analgesia or are not expected to provide adequate analgesia. oxycodone hydrochloride tablets is contraindicated in patients with: • significant respiratory depression [see warnings and precautions (5.3)]. • acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment or hypercarbia [see warnings and precautions (5.7)]. • known or suspected gastrointestinal obstruction, in
minoxidil tablet
par pharmaceutical, inc. - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - minoxidil 10 mg - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mmhg or to 90 mmhg or less in approximately 75% of patients, most of who had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
minoxidil tablet
state of florida doh central pharmacy - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - minoxidil 10 mg - because of the potential for serious adverse effects, minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of diuretic plus two other antihypertensive drugs. at the present time use in milder degrees of hypertension is not recommended because the benefit-risk relationship in such patients has not been defined. minoxidil reduced supine diastolic blood pressure by 20 mmhg or to 90 mmhg or less in approximately 75% of patients, most of whom had hypertension that could not be controlled by other drugs. minoxidil tablets are contraindicated in pheochromocytoma, because it may stimulate secretion of catecholamines from the tumor through its antihypertensive action. minoxidil is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
minoxidil tablet
cardinal health - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - minoxidil 2.5 mg
leukeran
excella gmbh & co.kg - chlorambucil - tablets film-coated - 2mg
nithiodote solution for injection
hope pharmaceuticals ltd - sodium thiosulfate; sodium nitrite - solution for injection - 30/250 milligram(s)/millilitre - antidotes; thiosulfate; sodium nitrite
minocin sa 100 mg modified release capsules
mylan ire healthcare limited - minocycline hydrochloride - modified-release capsule, hard - 100 mg milligram(s) - tetracyclines; minocycline